Skip to Content

We invite you to try out our new beta eCFR site at We’ve made big changes to make the eCFR easier to use. Be sure to leave feedback using the 'Help' button on the bottom right of each page!


Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Enhanced Content

Relevant information about this document from provides additional context. This information is not part of the official Federal Register document.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble


Food and Drug Administration, HHS.




The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

Start Further Info


Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726,

End Further Info End Preamble Start Supplemental Information


The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at​public/​do/​PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.

Table 1—List of Information Collections Approved by OMB

Title of collectionOMB control No.Date approval expires
Formal Meetings Between the Food and Drug Administration and Sponsors and Applicants of Prescription Drug User Fee Act Products0910-04295/31/2023
Special Protocol Assessments0910-04705/31/2023
Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements0910-06065/31/2023
Tracking Network for PETNet, LivestockNet, and SampleNet0910-06805/31/2023
Center for Tobacco Products, Food and Drug Administration Funded Trainee/Scholar Survey0910-08875/31/2023
Importer's Entry Notice0910-00466/30/2023
Premarket Notification Submission 510(k), Subpart E0910-01206/30/2023
Medical Devices; Pediatric Uses of Devices; Requirement for Submission of Information on Pediatric Subpopulations0910-07486/30/2023
Controlled Correspondence Related to Generic Drug Development0910-07976/30/2023
Certification of Identity for Freedom of Information Act and Privacy Act Requests0910-08326/30/2023
FDA Advisory Committee Membership Nominations0910-08336/30/2023
Start Signature

Dated: July 6, 2020.

Lowell J. Schiller,

Principal Associate Commissioner for Policy.

End Signature End Supplemental Information

[FR Doc. 2020-14875 Filed 7-9-20; 8:45 am]